by Kolapo Olapoju
Mapp Biopharmaceutical Inc, a company in San Diego, has come up with an experimental Ebola treatment which appears to be working on two Americans who were infected with the deadly Ebola virus in Liberia.
The biotechnology drug is ZMapp, and it is produced with tobacco plants. Up until recently, the drug hadn’t been certified for humans as it had only been tested on animals.
Its use has now made the two health workers get better.
The first patient, Kent Brantly, a doctor,who was flown from Liberia to Atlanta on 2 Aug, is receiving treatment at Emory University Hospital, while Nancy Writebol, an aid worker, is scheduled to arrive in Atlanta today, 5 August, and will be treated at the same hospital.
Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases disclosed that each patient received at least one dose of ZMapp in Liberia before coming to the United States.
He said, “There’s a very scarce number of doses,” and it’s not clear how many each patient needs for treatment. I’m not sure how many doses they’ll get.
There is no cure for Ebola, although several companies, including ‘Mapp are working on drug candidates that are undergoing animal testing to find a permanent cure for the deadly disease.
Kudos to americans by using God’s ability made available.